✦ LIBER ✦

Interaction of polylysine-[HAV-VP3 peptide] constructs with DPPC mono and bilayers

✍ Scribed by P. Sospedra; I. B. Nagy; I. Haro; C. Mestres; F. Hudecz; F. Reig

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 45 KB
Volume: 13
Category: Article
ISSN: 0269-3879
DOI: 10.1002/(sici)1099-0801(199904)13:2<159::aid-bmc846>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction with Phospholipid Mono- and

Interaction with Phospholipid Mono- and Bi-layers of HAV-VP3 (102–121) Sequence by Using Spectroscopic Techniques

✍ M. Garcia; M. Pujol; F. Reig; M. A. Alsina; I. Haro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Figure 1. Pressure increases recorded after injection of (a) VP3 (102-121); (b) palmitoyl-VP3 (102-121); (c) reference MLV liposomes/VP3 (102-121) entrapped into MLV liposomes; (d) reference MLV liposomes/ palmitoyl-VP3 (102-121) incorporated into MLV liposomes under DPPC monolayers spread at 5, 10,

Effect of chain length of HAV-VP3 synthe

Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models

✍ P. Sospedra; M. Muñoz; M. García; M. A. Alsina; C. Mestres; I. Haro 📂 Article 📅 2000 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 194 KB

Interaction of VP3(110–121) Peptide with

Interaction of VP3(110–121) Peptide with Hepatocyte and Erythrocyte Membrane Models

✍ P. Sospedra; M.A. Alsina; I. Haro; C. Mestres; M.A. Busquets 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 159 KB

The use of synthetic peptides in the goal of developing a new, inexpensive vaccine against hepatitis A virus is one of the encouraging approaches followed by many laboratories. These peptides have to be well characterized, being their physicochemical properties one of the most relevant points to con